Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Reactive astrocyte-driven epileptogenesis is induced by microglia initially activated following status epilepticus
Fumikazu Sano, Eiji Shigetomi, Youichi Shinozaki, Haruka Tsuzukiyama, Kozo Saito, Katsuhiko Mikoshiba, Hiroshi Horiuchi, Dennis Lawrence Cheung, Junichi Nabekura, Kanji Sugita, Masao Aihara, Schuichi Koizumi
Fumikazu Sano, Eiji Shigetomi, Youichi Shinozaki, Haruka Tsuzukiyama, Kozo Saito, Katsuhiko Mikoshiba, Hiroshi Horiuchi, Dennis Lawrence Cheung, Junichi Nabekura, Kanji Sugita, Masao Aihara, Schuichi Koizumi
View: Text | PDF
Research Article Neuroscience

Reactive astrocyte-driven epileptogenesis is induced by microglia initially activated following status epilepticus

  • Text
  • PDF
Abstract

Extensive activation of glial cells during a latent period has been well documented in various animal models of epilepsy. However, it remains unclear whether activated glial cells contribute to epileptogenesis, i.e., the chronically persistent process leading to epilepsy. Particularly, it is not clear whether interglial communication between different types of glial cells contributes to epileptogenesis, because past literature has mainly focused on one type of glial cell. Here, we show that temporally distinct activation profiles of microglia and astrocytes collaboratively contributed to epileptogenesis in a drug-induced status epilepticus model. We found that reactive microglia appeared first, followed by reactive astrocytes and increased susceptibility to seizures. Reactive astrocytes exhibited larger Ca2+ signals mediated by IP3R2, whereas deletion of this type of Ca2+ signaling reduced seizure susceptibility after status epilepticus. Immediate, but not late, pharmacological inhibition of microglial activation prevented subsequent reactive astrocytes, aberrant astrocyte Ca2+ signaling, and the enhanced seizure susceptibility. These findings indicate that the sequential activation of glial cells constituted a cause of epileptogenesis after status epilepticus. Thus, our findings suggest that the therapeutic target to prevent epilepsy after status epilepticus should be shifted from microglia (early phase) to astrocytes (late phase).

Authors

Fumikazu Sano, Eiji Shigetomi, Youichi Shinozaki, Haruka Tsuzukiyama, Kozo Saito, Katsuhiko Mikoshiba, Hiroshi Horiuchi, Dennis Lawrence Cheung, Junichi Nabekura, Kanji Sugita, Masao Aihara, Schuichi Koizumi

×

Figure 2

Reactive astrocytes exhibit IP3R2-mediated Ca2+ hyperactivity, which is essential for epileptogenesis.

Options: View larger image (or click on image) Download as PowerPoint
Reactive astrocytes exhibit IP3R2-mediated Ca2+ hyperactivity, which is ...
(A–C) Ca2+ dynamics of astrocytes approximately 4 weeks after SE in the CA1 stratum radiatum region in Glast-CreERT2 flx-GCaMP3 mice before and after TTX (1 μM) (A), CPA (20 μM) (B), and 2-APB (100 μM) (C) application. (D–I) Box plots showing amplitudes of Ca2+ signals before and after TTX (1 μM) (D), CPA (20 μM) (F), and 2-APB (100 μM) (H) application (n = 2 mice and 10 cells [D], 13 cells [F], and 14 cells [H]; ***P < 0.001, unpaired t test). Cumulative probability plots showing amplitudes (dF/F) of Ca2+ signals before and after TTX (NS P > 0.05, Kolmogorov–Smirnov test) (E), CPA (P < 0.001, Kolmogorov–Smirnov test) (G), and 2-APB (P < 0.001, Kolmogorov–Smirnov test) (I) application. (J) Astrocytic Ca2+ dynamics by Fluo4 in the CA1 stratum radiatum region in WT control, WT after SE, and IP3R2-KO mice after SE. (K–N) Box plots showing Ca2+ signal amplitudes (dF/F) (K) and frequency (M) (n = 57 cells and 2 mice [control], 32 cells and 2 mice [SE], and 85 cells and 3 mice [IP3R2KO SE]; ***P < 0.001, unpaired t test). Cumulative probability plots showing Ca2+ signal amplitudes (dF/F) (L) and frequency (N) (P < 0.001, Kolmogorov–Smirnov test). (O) Dot plots showing dose of pilocarpine required for the induction of the second SE in IP3R2-KO mice. Mice were injected with saline (SP) or pilocarpine (PP) at 8 weeks of age followed by an injection of pilocarpine at 12 weeks of age (n = 10 mice; NS P > 0.05, Mann–Whitney U test). (P) Scatter plot showing dose of pilocarpine required for the induction of the first (at 8 weeks of age) and second (at 12 weeks of age) SE in the PP group regarding IP3R2-KO mice (n = 10 mice; NS P > 0.05, Wilcoxon signed-rank test). Note: The first pilocarpine did not affect the dose required for the second SE in IP3R2-KO; see Figure 1G. TTX, tetrodotoxin; CPA, cyclopiazonic acid; 2-APB, 2-aminoethoxydiphenyl borate; Cont, control.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts